Annual Operating Profit
$55.16 M
+$13.81 M+33.40%
31 December 2023
Summary:
Core Laboratories NV annual operaing income is currently $55.16 million, with the most recent change of +$13.81 million (+33.40%) on 31 December 2023. During the last 3 years, it has fallen by -$2.44 million (-4.24%). CLB annual operating profit is now -84.13% below its all-time high of $347.60 million, reached on 31 December 2014.CLB Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
$15.27 M
+$1.66 M+12.16%
30 September 2024
Summary:
Core Laboratories NV quarterly operating income is currently $15.27 million, with the most recent change of +$1.66 million (+12.16%) on 30 September 2024. Over the past year, it has dropped by -$407.00 thousand (-2.60%). CLB quarterly operating profit is now -83.31% below its all-time high of $91.53 million, reached on 31 December 2014.CLB Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
$53.13 M
-$407.00 K-0.76%
30 September 2024
Summary:
Core Laboratories NV TTM operating income is currently $53.13 million, with the most recent change of -$407.00 thousand (-0.76%) on 30 September 2024. Over the past year, it has dropped by -$2.26 million (-4.08%). CLB TTM operating profit is now -84.72% below its all-time high of $347.60 million, reached on 31 December 2014.CLB TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLB Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +33.4% | -2.6% | -4.1% |
| 3 y3 years | -4.2% | +179.9% | +3.1% |
| 5 y5 years | -53.2% | -49.9% | -44.2% |
CLB Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -4.2% | +38.0% | -14.4% | +832.2% | -8.0% | +96.9% |
| 5 y | 5 years | -53.2% | +38.0% | -49.9% | +832.2% | -47.8% | +96.9% |
| alltime | all time | -84.1% | +446.1% | -83.3% | +832.2% | -84.7% | +374.3% |
Core Laboratories NV Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $15.27 M(+12.2%) | $53.13 M(-0.8%) |
| June 2024 | - | $13.62 M(+40.3%) | $53.53 M(-7.3%) |
| Mar 2024 | - | $9.71 M(-33.2%) | $57.75 M(+5.3%) |
| Dec 2023 | $55.16 M(+33.4%) | $14.53 M(-7.4%) | $54.83 M(-1.0%) |
| Sept 2023 | - | $15.68 M(-12.1%) | $55.38 M(+5.1%) |
| June 2023 | - | $17.84 M(+163.1%) | $52.70 M(+12.8%) |
| Mar 2023 | - | $6.78 M(-55.1%) | $46.73 M(+23.4%) |
| Dec 2022 | $41.35 M(+3.4%) | $15.09 M(+16.1%) | $37.87 M(+5.4%) |
| Sept 2022 | - | $13.00 M(+9.5%) | $35.91 M(+26.6%) |
| June 2022 | - | $11.87 M(-669.0%) | $28.37 M(+5.1%) |
| Mar 2022 | - | -$2.09 M(-115.9%) | $26.99 M(-32.5%) |
| Dec 2021 | $39.97 M(-30.6%) | $13.13 M(+140.7%) | $39.97 M(-22.4%) |
| Sept 2021 | - | $5.46 M(-48.0%) | $51.53 M(-8.5%) |
| June 2021 | - | $10.48 M(-3.8%) | $56.31 M(+0.1%) |
| Mar 2021 | - | $10.90 M(-55.8%) | $56.24 M(-2.4%) |
| Dec 2020 | $57.60 M(-43.5%) | $24.69 M(+141.0%) | $57.60 M(+1.7%) |
| Sept 2020 | - | $10.24 M(-1.6%) | $56.63 M(-26.3%) |
| June 2020 | - | $10.41 M(-15.1%) | $76.89 M(-19.3%) |
| Mar 2020 | - | $12.26 M(-48.3%) | $95.28 M(-6.4%) |
| Dec 2019 | $102.00 M(-13.5%) | $23.72 M(-22.2%) | $101.80 M(+7.0%) |
| Sept 2019 | - | $30.50 M(+5.9%) | $95.15 M(-4.5%) |
| June 2019 | - | $28.80 M(+53.3%) | $99.67 M(-4.6%) |
| Mar 2019 | - | $18.79 M(+10.1%) | $104.50 M(-11.4%) |
| Dec 2018 | $117.89 M(+6.6%) | $17.07 M(-51.2%) | $117.89 M(-11.3%) |
| Sept 2018 | - | $35.01 M(+4.1%) | $132.95 M(+6.7%) |
| June 2018 | - | $33.63 M(+4.5%) | $124.59 M(+5.4%) |
| Mar 2018 | - | $32.17 M(+0.1%) | $118.25 M(+6.9%) |
| Dec 2017 | $110.60 M(+27.1%) | $32.14 M(+20.6%) | $110.60 M(+9.3%) |
| Sept 2017 | - | $26.65 M(-2.4%) | $101.20 M(+5.7%) |
| June 2017 | - | $27.29 M(+11.3%) | $95.75 M(+8.0%) |
| Mar 2017 | - | $24.53 M(+7.9%) | $88.64 M(+1.8%) |
| Dec 2016 | $87.05 M(-53.6%) | $22.73 M(+7.2%) | $87.05 M(-15.5%) |
| Sept 2016 | - | $21.20 M(+5.1%) | $103.01 M(-21.3%) |
| June 2016 | - | $20.18 M(-12.0%) | $130.96 M(-18.4%) |
| Mar 2016 | - | $22.94 M(-40.7%) | $160.49 M(-14.5%) |
| Dec 2015 | $187.68 M(-46.0%) | $38.70 M(-21.3%) | $187.68 M(-22.0%) |
| Sept 2015 | - | $49.15 M(-1.1%) | $240.52 M(-14.5%) |
| June 2015 | - | $49.71 M(-0.8%) | $281.42 M(-10.3%) |
| Mar 2015 | - | $50.13 M(-45.2%) | $313.65 M(-9.8%) |
| Dec 2014 | $347.60 M(+4.4%) | $91.53 M(+1.7%) | $347.60 M(+1.2%) |
| Sept 2014 | - | $90.05 M(+9.9%) | $343.56 M(+1.6%) |
| June 2014 | - | $81.94 M(-2.5%) | $338.15 M(-0.2%) |
| Mar 2014 | - | $84.08 M(-3.9%) | $338.71 M(+1.7%) |
| Dec 2013 | $333.08 M(+13.6%) | $87.50 M(+3.4%) | $333.08 M(+3.7%) |
| Sept 2013 | - | $84.64 M(+2.6%) | $321.28 M(+3.7%) |
| June 2013 | - | $82.50 M(+5.2%) | $309.77 M(+2.4%) |
| Mar 2013 | - | $78.45 M(+3.6%) | $302.61 M(+3.2%) |
| Dec 2012 | $293.16 M(+17.3%) | $75.70 M(+3.5%) | $293.16 M(+1.5%) |
| Sept 2012 | - | $73.12 M(-2.9%) | $288.85 M(+3.0%) |
| June 2012 | - | $75.34 M(+9.2%) | $280.53 M(+6.6%) |
| Mar 2012 | - | $68.99 M(-3.3%) | $263.14 M(+5.7%) |
| Dec 2011 | $249.84 M(+11.2%) | $71.38 M(+10.1%) | $248.85 M(+5.1%) |
| Sept 2011 | - | $64.81 M(+11.8%) | $236.84 M(+2.0%) |
| June 2011 | - | $57.95 M(+5.9%) | $232.25 M(+1.9%) |
| Mar 2011 | - | $54.71 M(-7.9%) | $228.02 M(+1.5%) |
| Dec 2010 | $224.72 M(+20.3%) | $59.37 M(-1.4%) | $224.72 M(+7.2%) |
| Sept 2010 | - | $60.22 M(+12.1%) | $209.63 M(+8.3%) |
| June 2010 | - | $53.72 M(+4.5%) | $193.61 M(+1.1%) |
| Mar 2010 | - | $51.41 M(+16.1%) | $191.52 M(+1.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | $186.78 M(-9.8%) | $44.28 M(+0.2%) | $187.97 M(-4.3%) |
| Sept 2009 | - | $44.20 M(-14.4%) | $196.39 M(-5.2%) |
| June 2009 | - | $51.63 M(+7.9%) | $207.26 M(-1.6%) |
| Mar 2009 | - | $47.86 M(-9.2%) | $210.54 M(+1.7%) |
| Dec 2008 | $207.06 M(+12.6%) | $52.70 M(-4.3%) | $206.94 M(-3.1%) |
| Sept 2008 | - | $55.07 M(+0.3%) | $213.51 M(+4.5%) |
| June 2008 | - | $54.91 M(+24.1%) | $204.40 M(+6.8%) |
| Mar 2008 | - | $44.26 M(-25.3%) | $191.39 M(+4.1%) |
| Dec 2007 | $183.85 M(+48.8%) | $59.27 M(+29.0%) | $183.85 M(+14.0%) |
| Sept 2007 | - | $45.96 M(+9.7%) | $161.34 M(+8.2%) |
| June 2007 | - | $41.90 M(+14.1%) | $149.17 M(+7.8%) |
| Mar 2007 | - | $36.72 M(-0.1%) | $138.43 M(+9.8%) |
| Dec 2006 | $123.56 M(+102.8%) | $36.76 M(+8.8%) | $126.10 M(+19.0%) |
| Sept 2006 | - | $33.79 M(+8.4%) | $105.94 M(+22.8%) |
| June 2006 | - | $31.16 M(+27.8%) | $86.28 M(+21.0%) |
| Mar 2006 | - | $24.39 M(+46.9%) | $71.29 M(+17.0%) |
| Dec 2005 | $60.93 M(+31.0%) | $16.60 M(+17.4%) | $60.93 M(+2.7%) |
| Sept 2005 | - | $14.14 M(-12.5%) | $59.31 M(+1.3%) |
| June 2005 | - | $16.16 M(+15.2%) | $58.54 M(+14.6%) |
| Mar 2005 | - | $14.03 M(-6.4%) | $51.08 M(+9.4%) |
| Dec 2004 | $46.51 M(+29.5%) | $14.98 M(+12.1%) | $46.71 M(+6.9%) |
| Sept 2004 | - | $13.37 M(+53.5%) | $43.70 M(+2.7%) |
| June 2004 | - | $8.71 M(-9.8%) | $42.57 M(+1.5%) |
| Mar 2004 | - | $9.65 M(-19.4%) | $41.95 M(+16.2%) |
| Dec 2003 | $35.92 M(+56.3%) | $11.98 M(-2.1%) | $36.11 M(+8.2%) |
| Sept 2003 | - | $12.23 M(+51.1%) | $33.38 M(+17.5%) |
| June 2003 | - | $8.09 M(+112.4%) | $28.40 M(+3.1%) |
| Mar 2003 | - | $3.81 M(-58.8%) | $27.54 M(-9.5%) |
| Dec 2002 | $22.98 M(-41.9%) | $9.24 M(+27.3%) | $30.45 M(+29.1%) |
| Sept 2002 | - | $7.26 M(+0.3%) | $23.59 M(-23.6%) |
| June 2002 | - | $7.23 M(+7.8%) | $30.85 M(-12.8%) |
| Mar 2002 | - | $6.71 M(+181.7%) | $35.40 M(-10.5%) |
| Dec 2001 | $39.55 M(+15.0%) | $2.38 M(-83.6%) | $39.55 M(-19.3%) |
| Sept 2001 | - | $14.52 M(+23.3%) | $48.99 M(+10.5%) |
| June 2001 | - | $11.78 M(+8.4%) | $44.32 M(+10.7%) |
| Mar 2001 | - | $10.87 M(-8.1%) | $40.02 M(+16.1%) |
| Dec 2000 | $34.39 M(+80.6%) | $11.82 M(+20.0%) | $34.47 M(+35.8%) |
| Sept 2000 | - | $9.85 M(+31.7%) | $25.39 M(-1.0%) |
| June 2000 | - | $7.48 M(+40.6%) | $25.64 M(+13.9%) |
| Mar 2000 | - | $5.32 M(+93.9%) | $22.50 M(+19.2%) |
| Dec 1999 | $19.04 M(-49.4%) | $2.74 M(-72.9%) | $18.87 M(-16.3%) |
| Sept 1999 | - | $10.10 M(+132.5%) | $22.55 M(-15.7%) |
| June 1999 | - | $4.34 M(+157.3%) | $26.75 M(-18.5%) |
| Mar 1999 | - | $1.69 M(-73.7%) | $32.81 M(-13.3%) |
| Dec 1998 | $37.62 M(+24.6%) | $6.42 M(-55.1%) | $37.82 M(-13.1%) |
| Sept 1998 | - | $14.30 M(+37.5%) | $43.50 M(+15.7%) |
| June 1998 | - | $10.40 M(+55.2%) | $37.60 M(+10.9%) |
| Mar 1998 | - | $6.70 M(-44.6%) | $33.90 M(+11.9%) |
| Dec 1997 | $30.20 M(+141.6%) | $12.10 M(+44.0%) | $30.30 M(+39.6%) |
| Sept 1997 | - | $8.40 M(+25.4%) | $21.70 M(+30.7%) |
| June 1997 | - | $6.70 M(+116.1%) | $16.60 M(+27.7%) |
| Mar 1997 | - | $3.10 M(-11.4%) | $13.00 M(+2.4%) |
| Dec 1996 | $12.50 M(+23.8%) | $3.50 M(+6.1%) | $12.70 M(+6.7%) |
| Sept 1996 | - | $3.30 M(+6.5%) | $11.90 M(+6.3%) |
| June 1996 | - | $3.10 M(+10.7%) | $11.20 M(-58.1%) |
| Mar 1996 | - | $2.80 M(+3.7%) | $26.70 M(-36.0%) |
| Dec 1995 | $10.10 M | $2.70 M(+3.8%) | $41.70 M(+6.9%) |
| Sept 1995 | - | $2.60 M(-86.0%) | $39.00 M(+7.1%) |
| June 1995 | - | $18.60 M(+4.5%) | $36.40 M(+104.5%) |
| Mar 1995 | - | $17.80 M | $17.80 M |
FAQ
- What is Core Laboratories NV annual operaing income?
- What is the all time high annual operating profit for Core Laboratories NV?
- What is Core Laboratories NV annual operating profit year-on-year change?
- What is Core Laboratories NV quarterly operating income?
- What is the all time high quarterly operating profit for Core Laboratories NV?
- What is Core Laboratories NV quarterly operating profit year-on-year change?
- What is Core Laboratories NV TTM operating income?
- What is the all time high TTM operating profit for Core Laboratories NV?
- What is Core Laboratories NV TTM operating profit year-on-year change?
What is Core Laboratories NV annual operaing income?
The current annual operating profit of CLB is $55.16 M
What is the all time high annual operating profit for Core Laboratories NV?
Core Laboratories NV all-time high annual operaing income is $347.60 M
What is Core Laboratories NV annual operating profit year-on-year change?
Over the past year, CLB annual operaing income has changed by +$13.81 M (+33.40%)
What is Core Laboratories NV quarterly operating income?
The current quarterly operating profit of CLB is $15.27 M
What is the all time high quarterly operating profit for Core Laboratories NV?
Core Laboratories NV all-time high quarterly operating income is $91.53 M
What is Core Laboratories NV quarterly operating profit year-on-year change?
Over the past year, CLB quarterly operating income has changed by -$407.00 K (-2.60%)
What is Core Laboratories NV TTM operating income?
The current TTM operating profit of CLB is $53.13 M
What is the all time high TTM operating profit for Core Laboratories NV?
Core Laboratories NV all-time high TTM operating income is $347.60 M
What is Core Laboratories NV TTM operating profit year-on-year change?
Over the past year, CLB TTM operating income has changed by -$2.26 M (-4.08%)